Swallowable camera capsule to image the small intestine in celiac disease
Tests a swallowed imaging capsule in people with celiac disease and healthy volunteers.
Key facts
- Who runs it
- Massachusetts General Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Imaging the Duodenum Using an Optical Frequency Domain Imaging OFDI Capsule
- Status
- Enrolling by invitation
- People taking part
- 108 people, planned
- Started
- 16 Sept 2013
- Expected to end
- Jul 2030
- Type of study
- Interventional
- Treatments tested
- OFDI Capsule
- Record updated
- 10 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for healthy volunteers and people with suspected or diagnosed Celiac disease. They will swallow a capsule on a thin cord that takes images of the first part of the small bowel (duodenum).
- Age
- Healthy volunteers: over 18 years. People with Celiac disease: over 16 years.
- Sex
- All sexes can join.
- Disease stage
- Celiac disease that is clinically suspected or diagnosed, or healthy with no disease.
Main reasons for not taking part
- Cannot swallow pills or capsules
- Abnormal openings (fistulas) in the food pipe or bowel
- Known narrowing of the food pipe or bowel smaller than the capsule
- History of Crohn's disease of the bowel
- Pregnant women
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Participant must be over 18 years for healthy volunteers
- Participants must be over 16 years for patients with Celiac disease
- Participant must be able to give informed consent
Who cannot take part
- Participants with a history of intestinal Crohn's disease
- Participants with an inability to swallow pills or capsules
- Participants with esophageal or intestinal fistulas
- Participants with known esophageal or intestinal strictures resulting in a luminal diameter smaller than the diameter of the capsule
- Women who are pregnant
Where in United States
- Massachusetts General HospitalBoston, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The study is being done to assess the tolerability and feasibility of a tethered OFDI capsule to image the duodenum.
Read full original descriptionShow less
A total of 108 participants (36 healthy and 72 with clinically suspected or diagnosed Celiac disease) will be asked to swallow the tethered capsule, while they are awake and unsedated and ask for their feedback. Images will be taken using the OFDI system while the capsule travels from the esophagus into the stomach and into the duodenum.
The group in the trial
- OFDI Capsule ImagingTreatment being tested
Participant will swallow the OFDI Capsule and imaging will be performed using the OFDI system.
Treatment: OFDI Capsule
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pilot Study for Imaging of the Duodenum Using an OFDI Capsule
- Plain-language title
- Swallowable camera capsule to image the small intestine in celiac diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 10 November 2026